步长制药：第五届董事会第三十次会议决议公告

Core Viewpoint - The company, Buchang Pharmaceutical, announced the approval of several proposals, including the 2025 semi-annual report and summary, during the 30th meeting of its fifth board of directors [2] Group 1 - The company held its fifth board of directors' 30th meeting on August 27 [2] - The meeting resulted in the approval of the 2025 semi-annual report and summary [2]